Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma

Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphomaAllogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma, Published online: 30 April 2018; doi:10.1038/s41409-018-0184-7Allogeneic hematopoietic stem cell transplantation should be in preference to conventional chemotherapy as post-remission treatment for adults with lymphoblastic lymphoma

Source: Bone Marrow Transplantation - April 30, 2018 Category: Hematology Authors: Luxin Yang Yamin Tan Jimin Shi Yanmin Zhao Yuanyuan Zhu Yongxian Hu Wenjue Pan Yishan Ye Jingsong He Weiyan Zheng Jie Sun Zhen Cai He Huang Yi Luo Source Type: research